Circulating TGFβ in Marfan's Syndrome

BACKGROUND: Marfan syndrome (MFS) is caused by mutations in the fibrillin-1 gene and dysregulation of transforming growth factor β (TGFβ). Recent evidence suggests that losartan, an AT1 blocker that blunts TGFβ activation, may be an effective treatment for MFS. We hypothesized that dysregulation of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Matt, Peter, Schoenhoff, Florian, Habashi, Jennifer, Holm, Tammy, Van Erp, Christel, Loch, David, Carlson, Olga D., Griswold, Benjamin F., Fu, Qin, De Backer, Julie, Loeys, Bart, Huso, David, McDonnell, Nazli B., Van Eyk, Jennifer E., Dietz, Harry C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2779568/
https://ncbi.nlm.nih.gov/pubmed/19635970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.108.841981
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados